Currentpartners_health_managementPolicy CP.MP.98

Clinical Policy: Urodynamic Testing

Customize your policy alerts

Sign up for partners_health_management Policy CP.MP.98 alerts

Get alerted when Policy CP.MP.98 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines medical necessity criteria, coding, and coverage stance for urodynamic studies used in evaluating voiding dysfunction for members/enrollees of the payer.

Policy Summary

Payerpartners_health_management

PolicyClinical Policy: Urodynamic Testing

Policy CodePolicy CP.MP.98

Change TypeNo material changes noted

Effective Date

Next Review Date

Key ActionProvide documentation of supporting diagnosis codes and evidence that medical necessity criteria are met when requesting coverage for urodynamic procedure codes.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Multipleurodynamic procedure codes referenced

Extensivediagnosis codes supporting medical necessity

>1 per visitspecific denial rule

51792coding table addition

09/15

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

Currentpartners_health_managementPolicy CP.MP.98

Clinical Policy: Urodynamic Testing

Customize your policy alerts

Sign up for partners_health_management Policy CP.MP.98 alerts

Get alerted when Policy CP.MP.98 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines medical necessity criteria, coding, and coverage stance for urodynamic studies used in evaluating voiding dysfunction for members/enrollees of the payer.

Policy Summary

Payerpartners_health_management

PolicyClinical Policy: Urodynamic Testing

Policy CodePolicy CP.MP.98

Change TypeNo material changes noted

Effective Date

Next Review Date

Key ActionProvide documentation of supporting diagnosis codes and evidence that medical necessity criteria are met when requesting coverage for urodynamic procedure codes.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Multipleurodynamic procedure codes referenced

Extensivediagnosis codes supporting medical necessity

>1 per visitspecific denial rule

51792coding table addition

09/15

original development

Coverage Criteria for Urodynamic Testing

Medically Necessary Indications

Urodynamic testing is medically necessary to assist in diagnosis when any of the following indications are present:

Indications for medical necessity: A. Uncertain diagnosis and inability to develop an appropriate initial treatment plan based on the clinical diagnostic evaluation

Indications for medical necessity: B. Failure to respond to an adequate therapeutic trial

Indications for medical necessity: C. Consideration of urologic surgical intervention, particularly if previous surgery failed or if the patient is a high surgical risk

Indications for medical necessity

D1: Urinary incontinence
D2: Persistent symptoms of difficult bladder emptying
D3: History of previous anti-incontinence surgery or radical pelvic surgery
D4: Symptomatic pelvic prolapse
D5: Prostate nodule, asymmetry or other suspicion of prostate cancer
D6: Abnormal post void residual urine volume
D7: Diabetes mellitus with secondary urinary incontinence
D8: Neurological conditions affecting voiding function (neurogenic bladder) such as multiple sclerosis, Parkinson's disease, and spinal cord lesions or injury
D9: Complex anorectal malformation

ref

title

Not Medically Necessary

The following are considered not medically necessary:

Not medically necessary conditions: A. More than one cystometrogram (CPT codes 51725 or 51726) or uroflowmetry study (CPT codes 51736 or 51741) per visit

This is an explicit denial rule; multiple same-visit studies may be denied

Not medically necessary conditions: B. Use of any urodynamic testing for screening in asymptomatic patients, except for evaluation of neurogenic bladder or urological abnormalities associated with complex anorectal malformation

Screening exception for neurogenic bladder/complex anorectal malformation

Screening of asymptomatic patients with urodynamic testing is not medically necessary except when performed to evaluate neurogenic bladder or urological abnormalities associated with complex anorectal malformation. This exception recognizes that patients with neurological conditions affecting voiding function (for example, multiple sclerosis, Parkinson’s disease, or spinal cord lesions/injury) or those with complex anorectal malformations may require diagnostic urodynamic assessment even in the absence of classic LUTS.

Coverage for urodynamic testing is governed by the Health Plan’s overall terms and conditions. Decisions about medical necessity and benefit administration are subject to all applicable coverage documents (for example, evidence of coverage, certificate of coverage, policy or contract) and to state and federal requirements and any applicable plan-level administrative policies and procedures. Providers should verify alignment with these documents when submitting claims or authorization requests.

More than one cystometrogram (CPT codes 51725 or 51726) or more than one uroflowmetry study (CPT codes 51736 or 51741) performed during the same patient visit is considered not medically necessary and may be denied.

Coding — Procedure and Diagnosis Codes

Covered CPT CodesCPTCovered

51725	Simple cystometrogram (CMG) (eg, spinal manometer).
51726	Complex cystometrogram (ie, calibrated electronic equipment).
51727	Complex cystometrogram; with urethral pressure profile studies.
51728	Complex cystometrogram; with voiding pressure studies.
51729	Complex cystometrogram; with voiding pressure studies and urethral pressure profile studies.
51736	Simple uroflowmetry (UFR).
51741	Complex uroflowmetry.
51792	Stimulus evoked response (eg, measurement of bulbocavernous reflex latency time).
51797	Voiding pressure studies, intra-abdominal (list separately).
51798	Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging.

Not medically necessary when repeated same-visitCPTNot Covered

51725	Simple cystometrogram — more than one per visit is not medically necessary.
51726	Complex cystometrogram — more than one per visit is not medically necessary.
51736	Simple uroflowmetry — more than one per visit is not medically necessary.
51741	Complex uroflowmetry — more than one per visit is not medically necessary.

ICD-10 Codes Supporting Medical NecessityICD-10

A18.13	Tuberculosis of other urinary organs.
A52.10	Symptomatic neurosyphilis, unspecified.
C61	Malignant neoplasm of prostate.
E10.21	Type 1 diabetes mellitus with diabetic nephropathy.
G35	Multiple sclerosis.
G82.21	Paraplegia, unspecified.
N31.0	Neuromuscular dysfunction of bladder, not elsewhere classified (example in range).
N40.1	Benign prostatic hyperplasia with lower urinary tract symptoms.
N30.10	Interstitial cystitis (chronic) without hematuria.
R33.9	Retention of urine, unspecified.

1–10 of 12

1/2

ICD-10 codes supporting CPT 51798 and related proceduresmixedCovered

51798	CPT code referenced as supported by additional diagnosis codes
N13.8	Other obstructive and reflux uropathy
R33.0	Retention of urine
R35.0	Frequency of micturition

CPT additions (revision history)CPT

51792

CPT added to CPT coding table (per revision history)

Additional ICD-10 codes listed in revision historyICD-10Covered

T79.5XXA	Traumatic anuria, initial encounter
T79.5XXD	Traumatic anuria, subsequent encounter
T79.5XXS	Traumatic anuria, sequela
R39.12	Not elsewhere specified urinary symptom
R39.13	Other retention of urine
R39.16	Other specified urinary symptoms

Provider Actions, Documentation and Authorization

Documentation Required

Provide supporting diagnosis codes and clinical documentation

Urodynamic procedure codes listed in the policy may require evidence of supporting diagnosis codes and documentation that the medical necessity criteria are met prior to coverage. Ensure submitted claims or prior authorization requests include the ICD-10 diagnosis codes and clinical documentation that demonstrate one of the policy’s medically necessary indications.

Include relevant ICD-10 codes from the policy’s supporting diagnosis list with the CPT code.
Attach clinical notes showing how the patient meets a listed indication (e.g., failure of therapy, uncertain diagnosis, abnormal post-void residual).

Prior Authorization

Verify medical necessity and applicable coverage rules before authorization

Apply the medical necessity criteria in this clinical policy and verify any applicable Medicare NCDs/LCDs and state Medicaid provisions prior to authorization or claim submission. Certain CPTs referenced in the policy (for example CPT 51798 and 51792) are specifically noted and should be checked against NCD/LCD and state rules.

Background and Scope

Lower urinary tract symptoms (LUTS) encompass conditions such as urinary incontinence, frequency, urgency and nocturia and often have overlapping causes. Urodynamic studies (including cystometrograms, uroflowmetry, urethral pressure profiles and voiding pressure studies) measure bladder and abdominal pressures during filling and voiding to characterize storage and emptying dysfunction. Many urodynamic tests are invasive and may require urethral catheterization; because of potential risks (for example infection, trauma, or pain), clinicians should reserve invasive testing for situations where results will inform diagnosis or change management—such as uncertain diagnosis, failure of conservative therapy, consideration of surgery, or when comorbid conditions (for example neurogenic bladder or abnormal post-void residual) warrant further assessment.

Definitions — Procedure Descriptions

inv-21: Simple cystometrogram — CPT 51725 description

CPT code51725

NameSimple cystometrogram (CMG)

DescriptionPhysician inserts a pressure catheter into the bladder and, using a manometer (eg, spinal manometer), records bladder pressure and urinary flow.

NotesUsed to help distinguish bladder outlet obstruction from other voiding dysfunctions; requires prior initial evaluation (history, exam, urinalysis).

inv-22: Complex cystometrogram — CPT 51726 description and related codes

CPT code51726

Name

Policy Summary

Payerpartners_health_management

PolicyClinical Policy: Urodynamic Testing

Policy CodePolicy CP.MP.98

Change TypeNo material changes noted

Effective Date

Next Review Date

Key ActionProvide documentation of supporting diagnosis codes and evidence that medical necessity criteria are met when requesting coverage for urodynamic procedure codes.

SourceLink

On This Page

Review Medicare NCDs/LCDs and state Medicaid rules for consistency with this policy before requesting authorization.
Confirm any Health Plan-level administrative policies that may further affect coverage.

Step Therapy

Try conservative therapies before invasive urodynamic testing

Conservative, noninvasive treatments are generally acceptable prior to invasive urodynamic testing when clinically appropriate. Attempt pelvic muscle training, behavioral therapies, or appropriate pharmacotherapy before ordering invasive urodynamic studies unless clinically contraindicated.

Examples: pelvic muscle exercises (Kegel), bladder training/biofeedback, and pharmacotherapies (eg, anticholinergics).
Document response to conservative therapy in the record if claiming failure of an adequate therapeutic trial.

Note

Use referenced clinical guidance to inform reviews

Clinical guidelines and evidence sources cited in this policy may inform pre-authorization and review decisions, including AUA/SUFU guidelines, Cochrane systematic reviews, and UpToDate summaries.

AUA/SUFU guideline: Winters et al., J Urol. 2012.
Cochrane and UpToDate reviews cited in the References section.

Documentation Required

Complete required preliminary evaluation before testing

An initial evaluation must include at minimum an appropriate history, physical examination, and urinalysis with microscopy; if infection is present it should be treated and effectiveness of treatment observed before urodynamic testing is performed.

Document history and physical exam findings relevant to LUTS.
Include urinalysis/microscopy results and any treatment for infection with follow-up documentation prior to testing.

Prior Authorization

Align requests with coverage documents, contracts, and state rules

Ensure claims and prior authorization requests align with the applicable coverage documents (evidence of coverage, policy, contract) and with any applicable state Medicaid or Medicare NCD/LCD requirements referenced in this policy. Plan benefit documents and state/federal requirements may supersede or modify coverage.

Confirm that requested services are consistent with the member’s evidence of coverage and contract terms.
For Medicaid members, follow state Medicaid manual provisions when they conflict with this policy.

Billing Rule

Avoid billing multiple CMG or uroflowmetry studies per visit

More than one cystometrogram (CPT 51725 or 51726) or uroflowmetry study (CPT 51736 or 51741) performed during the same visit is considered not medically necessary and may be denied.

Do not bill multiple CMG (51725/51726) or multiple uroflowmetry (51736/51741) procedures for a single visit.
If multiple procedures are clinically claimed, provide documentation justifying medical necessity beyond routine practice.

Denial Risk

Be aware of denial risk from plan benefit limits and exclusions

Coverage decisions are subject to the terms, conditions, exclusions and limitations of the member’s coverage documents and applicable administrative policies; services may be denied based on plan benefit limits or exclusions.

A clinical determination of medical necessity under this policy does not guarantee payment if the service is excluded or limited by the member’s plan.
Check plan-level exclusions, limits, and administrative policies before performing or billing services.

Complex cystometrogram (CMG)

DescriptionUses transurethral catheter to fill the bladder while simultaneously obtaining rectal pressure with a transducer to measure intravesical pressure using calibrated electronic equipment.

Related codes51727 (CMG with urethral pressure profile), 51728 (CMG with voiding pressure studies), 51729 (CMG with voiding pressure and urethral pressure studies); 51797 = voiding pressure studies (listed separately).

inv-23: Simple uroflowmetry — CPT 51736 description

CPT code51736

NameSimple uroflowmetry (UFR)

DescriptionStopwatch method used to record the volume of urine flow over time (eg, stop-watch flow rate or mechanical uroflowmeter).

NotesNoninvasive option appropriate in some clinical scenarios as part of initial evaluation or follow-up.

inv-24: Complex uroflowmetry — CPT 51741 description

CPT code51741

NameComplex uroflowmetry

DescriptionUses calibrated electronic equipment to measure and record the volume and rate of urine flow over time.

NotesConsidered a more detailed/automated measurement compared with simple uroflowmetry; part of urodynamic test options.

inv-25: Post-void residual measurement — CPT 51798 description

CPT code51798

NameMeasurement of post-void residual urine (PVR)

DescriptionMeasurement of residual urine and/or bladder emptying capacity after voiding using ultrasound (non-imaging).

NotesMay be used as a noninvasive assessment alternative when clinically appropriate.

inv-26: Urodynamic studies — general definition and referenced guidance

DefinitionUrodynamic studies are diagnostic tests that assess bladder storage and voiding function, including cystometry, pressure-flow studies, uroflowmetry, urethral function testing, and post-void residual measurement.

Clinical contextMany urodynamic tests require urethral catheterization and carry risks (infection, urethral trauma, pain); initial evaluation (history, physical exam, urinalysis) should precede testing.

Guidance referencedAUA/SUFU guidelines, Cochrane reviews, and UpToDate are cited as supporting references informing appropriate use and interpretation of urodynamic testing.

Common componentsCystometrograms (simple and complex), voiding pressure studies, urethral pressure profiles, uroflowmetry (simple and complex), and ultrasound PVR measurement.